Abstract:Chimeric virus-like particles formed by the co-expression of HIV-1 gag capsid protein and surface proteins from other viruses can be used as a platform for production of a wide range of viral vaccines. These virus-like particles can be rapidly produced in an insect cell culture using the baculovirus expression vector system. However, a variety of different process-related impurities such as host cell proteins, double stranded DNA, chromatin, and structurally similar bionanoparticles like extracellular vesicles and baculovirus particles are present in the harvested supernatant and complicate the chromatographic purification steps. Heparan sulfate is the first entry point of a lot of enveloped viruses into the cell. Taking advantage of this functional property, its sub-variant, the glycosaminoglycan heparin immobilized on a chromatography media is a universal tool for the separation of enveloped virus-like particles. A purification process was developed consisting of clarification of the cell culture supernatant by membrane filtration, a pre-purification step using core–shell bead flow-through chromatography with CaptoTM Core 700, followed by heparin affinity chromatography with CaptoTM Heparin. The combination of CaptoTM Core 700 and CaptoTM Heparin allows for direct load of the flow-through material from the first into the second step without buffer exchange in between. In addition, lengthy buffer screening, as required for ion exchange and multimodal chromatography, can be omitted. Linear salt gradient elution in heparin affinity chromatography enabled separation of virus-like particles and baculovirus. The platformability of the process was demonstrated by purification of virus-like particles expressing influenza A virus hemagglutinin or neuraminidase, or SARS-CoV-2 spike protein as surface antigens and the virus-like particle without co-expressed surface protein. Western blotting, host cell protein and DNA assays, TCID50 (for residual baculovirus), mass spectrometry, multi-angle light scattering and nanoparticle tracking analysis were used to characterize the different fractions obtained during the purification. A similar elution profile was obtained for all tested virus-like particles and deviations could be explained by batch-to-batch variations and differences in productivity for the different constructs. Double stranded DNA was reduced to 7 – 36 ng/10 9 particles and host cell protein content was below the limit of quantification; in the main product fraction an average seven-fold reduction of baculovirus and a yield of 9 % − 14 % of bound particles with a concentration of 1.4 – 1.8 × 10 10 particles/mL in the eluate were achieved meeting requirements for a viral vaccine. Accordingly, this process is suitable as a downstream process platform for chimeric HIV-1 gag-based VLP products.

Purification of Cell‐derived Japanese Encephalitis Virus by Dual‐mode Chromatography

Concentration and Purification of Japanese Encephalitis Virus(JEV) Isolate CSF. XZ-2 D Propagated in BHK-21 Cells

Efficient Purification of Cell Culture-Derived Classical Swine Fever Virus by Ultrafiltration and Size-Exclusion Chromatography

Inline-tandem purification of viruses from cell lysate by agarose-based chromatography

Enterovirus71 Virus-Like Particles Produced from Insect Cells and Purified by Multistep Chromatography Elicit Strong Humoral Immune Responses in Mice

Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column

Amplification and Cloning of the Full-Length Genome of Japanese Encephalitis Virus by A Novel Long Rt-Pcr Protocol in A Cosmid Vector

Fluorescent Labeling Based Acoustofluidic Screening of Japanese Encephalitis Virus

A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9)

Development of a convenient immunochromatographic strip for the diagnosis of infection with Japanese encephalitis virus in swine.

A Novel Method to Purify Adenovirus Based on Increasing Salt Concentrations in Buffer

Purification of a recombinant oncolytic virus from clarified cell culture media by anion exchange monolith chromatography

In Vitro Inhibition of Japanese Encephalitis Virus Replication by Capsid-Targeted Virus Inactivation

Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies

At‐line multi‐angle light scattering detector for faster process development in enveloped virus‐like particle purification

Japanese encephalitis genotype I virus-like particles stably expressed in BHK-21 cells serves as potential antigen in JE IgM ELISA

Main Factors Influencing the Efficient Propagation of Virulent or Attenuated Strains of Japanese Encephalitis Virus in BHK-21 Cells

Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening

Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate

Heparin-affinity chromatography is a generic purification platform for chimeric gag VLPs displaying different viral surface antigens

[Method for Japanese Encephalitis Virus NS3 Protease Activity Analysis and High-Throughput Screening Assay for Inhibitors].